PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 8 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Clinical evidence
Extracts of S. luehmannii fruit and leaf displayed potent growth inhibitory properties against all tested Shewanella spp. [PMID: 28974817]
Aqueous and methanolic extracts of S. luehmannii were found to be good antifungal agents, inhibiting the growth of human dermatophytes [PMID: 31248775]
Evidence summary
PubMed sources
- 1.PMID: 29231777 (2018) — De Novo Transcriptome Study Identifies Candidate Genes Involved in Resistance to Austropuccinia psidii (Myrtle Rust) in Syzygium luehmannii (Riberry). · Phytopathology
- 2.PMID: 28974817 (2017) — Inhibition of Shewanella spp. growth by Syzygium australe and Syzygium luehmannii extracts: natural methods for the prevention of fish spoilage. · Journal of food science and technology
- 3.PMID: 31248775 (2019) — Inhibition of the growth of human dermatophytic pathogens by selected australian and asian plants traditionally used to treat fungal infections. · Journal de mycologie medicale